Researchers have identified a vitamin B12–based compound that can cross the blood-brain barrier and home in on glioblastoma tumors. In animal studies, the compound accumulated preferentially in tumor ...
Symptoms many dismiss may point to an overlooked cause, and catching it early could help prevent lasting health problems.
At its latest R&D update, Moderna revealed a move into the pioneering in vivo CAR-T category, adding another treatment class ...
The FDA’s approval of inebilizumab has heralded a new era for patients with IgG4-related disease, while novel agents moving ...
Round led by Pfizer Ventures, with participation from Deep Track Capital, GV, and founding investor, Aditum Bio ----LBL-051’s ability to reset ...
Sjögren’s disease (SjD) is a chronic, multisystem autoimmune disorder characterised by lymphocytic infiltration of exocrine ...
About Artiva Biotherapeutics Artiva is a clinical-stage biotechnology company whose mission is to develop effective, safe and accessible cell therapies for patients with debilitating autoimmune ...
Objectives CTA313 is a B-cell–directed cell therapy incorporating proprietary edits designed to improve in vivo kinetics and therapeutic durability. Methods Pts with SLE/LN received a single ...
Patients with lupus nephritis receiving obinutuzumab plus standard therapy demonstrated high rates of complete histologic remission.
Zucker School of Medicine at Hofstra/Northwell, New York, USA In summary, robust B-cell depletion with obinutuzumab was responsible for the attainment of significant effect sizes observed in NOBILITY ...
These 3 Perry Twp. siblings helped make medical history after successfully completing a stem cell treatment for a rare ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results